AzTrials
AzTrials

Early Childhood Caries (ECC)NCT07716033

Aesthetic and Functional Evaluation of a Universal One-Shade Composite in Primary Maxillary Incisors

A study testing Tokuyama Palfique Omnichroma composite restoration and 3M Filtek Z350 composite restoration in people with Early Childhood Caries (ECC), run by Goa Dental College at 1 site in India.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Use of tooth-coloured fillings is an essential part of Pediatric dentistry as most patients desire fillings which look like natural teeth. Lately, there is a vast variety of shade-choices in filling materials which complicates colour matching procedure, increases cost and increases treatment time. Read more about this study

Who is it for?
Ages 3 to 5 yearsHealthy volunteers can take part
Conditions the study is for
Early Childhood Caries (ECC)
What is being tested?
Tokuyama Palfique Omnichroma composite restoration and 3M Filtek Z350 composite restoration
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteIndia
Study dates
1 Mar 2025to 28 Feb 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 5 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Age group of 3-5 years
  • Carious lesions in both primary maxillary central incisors involving enamel or enamel and dentin only
  • Similar extent of carious lesion in both primary maxillary central incisors
  • Willing to give informed consent
  • Willing to return for evaluations and follow up

Who cannot join

  • Presence of pre shedding mobility
  • Deep carious lesions
  • Signs or symptoms of pulpal involvement
  • Presence of abscess, sinus tract, root resorption
  • Highly uncooperative patients
  • Medically compromised patients
  • Children with special health care needs

Trial locations and contacts

1 site in 1 country.

India1 site
  • Goa Dental College and Hospital

    Bambolim, Goa, 403202

Other trials in India

About this study

Official title: Evaluation of the Aesthetic and Functional Properties of A Universal One-Shade Composite Material With Chameleon-like Properties: A Longitudinal Split-Mouth Randomised Controlled Trial

  • Use of tooth-coloured fillings is an essential part of Pediatric dentistry as most patients desire fillings which look like natural teeth.
  • Lately, there is a vast variety of shade-choices in filling materials which complicates colour matching procedure, increases cost and increases treatment time.
  • Universal One shade composite filling materials have been developed to overcome these disadvantages. Omnichroma (Tokuyama Dental, USA) is one such material, introduced in 2019.
  • Manufacturer claims that it can match colour of surrounding tooth, irrespective of its shade, which may be an advantage for patients as well as pediatric dentists.
  • In child patients where chairside time, child's cooperation are important, this new one shade filling material Omnichroma, may prove to be better than multi shade composite filling materials, regarding color matching, color stability and other functional properties.
  • There are very few studies on this new material, that have assessed its actual performance in patients, and more studies would be useful to generate scientific evidence for dentists to use.
  • In this study we will fill one of your child's decayed front tooth with the new One shade filling material Omnichroma, and the other decayed front tooth with the usual conventional multi shade filling material 3M Filtek Z350 after colour matching followed by evaluation and taking of intraoral photographs.
  • You would be required to report for follow ups at 3, 6 and 12 months interval for a repeat evaluation and intraoral pictures.
Being tested
Tokuyama Palfique Omnichroma composite restoration, 3M Filtek Z350 composite restoration
Keywords
Omnichroma, Universal one-shade composite, Colour match, Colour stability, Aesthetic, Functional

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tokuyama Palfique Omnichroma composite restorationOther

    Tokuyama Palfique Omnichroma is a universal one-shade resin composite used for direct restoration of primary maxillary incisors.

  • 3M Filtek Z350 composite restorationOther

    3M Filtek Z350 XT is a nanofilled resin composite used as the active comparator for direct restoration of primary maxillary incisors.

Study groups in NCT07716033
Study groupRoleWhat they receive
Universal One-shade composite groupExperimentalNot described
Receives: Other: Tokuyama Palfique Omnichroma composite restoration
Conventional Multi-shade compositeActive comparatorNot described
Receives: Other: 3M Filtek Z350 composite restoration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Surface Luster and Surface texture

    Assessed using Revised FDI criteria 2023 Scores from 1-5 Higher scores indicate inferior outcome

    Measured: Baseline, 3 months, 6 months, and 12 months

  2. Marginal adaptation

    Assessed using Revised FDI criteria 2023 Scores from 1-5 Higher scores indicate inferior outcome

    Measured: Baseline, 3 months, 6 months, 12 months

  3. Marginal staining

    Assessed using Revised FDI criteria 2023 Scores from 1-5 Higher scores indicate inferior outcome

    Measured: Baseline, 3 months, 6 months, 12 months

  4. Fracture of material and retention

    Assessed using Revised FDI criteria 2023 Scores from 1-5 Higher scores indicate inferior outcome

    Measured: Baseline, 3 months, 6 months, 12 months

  5. Colour match

    Assessed using Revised FDI criteria 2023 Scores from 1-5 Higher scores indicate inferior outcome

    Measured: Baseline, 3 months, 6 months, 12 months

Secondary outcomes (2)
  1. Photographic/Digital Colour match

    A software was used to provide CIE L*, a*, and b* values for one point over the tooth surface (Pt B) and one point over the restoration (Pt A). The colour match/difference (ΔE) between the restoration (Pt A) and the adjacent tooth structure (Pt B) was calculated using the CIEDE2000 colour difference formula through the software algorithm. Lower ΔE values indicate a smaller colour discrepancy between the restoration and the surrounding tooth structure and were interpreted as better colour matching. Higher ΔE values indicate greater perceptible colour differences.

    Measured: Baseline, 3 months, 6 months, 12 months

  2. Photographic/ Digital Colour stability

    For the assessment of colour stability, ΔE values obtained at different follow-up intervals were compared over time at baseline (ΔE0), 3 months (ΔE₁), 6 months (ΔE₂) and 12 months (ΔE₃). Small differences in ΔE values across these time points were interpreted as indicating greater colour stability.

    Measured: Baseline, 3 months, 6 months, 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jul 2026
  2. Study start1 Mar 2025
  3. Primary completion28 Feb 2026
  4. Study completion28 Feb 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Split-mouth Randomised controlled trial
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07716033
Sponsor's protocol ID
GDCH/IEC/II-2024(18)
Status last verified
Jul 2026
First submitted
9 Jul 2026
Last updated
21 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Only summary study results will be made publicly available. Individual participant data and participant identifiers will not be shared to maintain confidentiality.

Publications

  • Bulut S, Sakci Z, Naderi S. Illumination of The Relationship between Ureter and Intervertebral Disc by Computed Tomography. Turk Neurosurg. 2021;31(3):466-471. doi: 10.5137/1019-5149.JTN.32650-20.4.

    PubMed 33624284
  • Araujo RLS, Correa JR, Galera PD. Ultrastructural morphology of goblet cells of the conjunctiva of dogs. Vet Ophthalmol. 2019 Nov;22(6):891-897. doi: 10.1111/vop.12667. Epub 2019 Apr 1.

    PubMed 30938063
  • Khanfar M, Al-Remawi M, Al-Akayleh F, Hmouze S. Preparation and Evaluation of Co-amorphous Formulations of Telmisartan-Amino Acids as a Potential Method for Solubility and Dissolution Enhancement. AAPS PharmSciTech. 2021 Mar 21;22(3):112. doi: 10.1208/s12249-021-01952-9.

    PubMed 33748914
  • Bauer A, Hegen H, Reindl M. Body fluid markers for multiple sclerosis and differential diagnosis from atypical demyelinating disorders. Expert Rev Mol Diagn. 2024 Apr;24(4):283-297. doi: 10.1080/14737159.2024.2334849. Epub 2024 Mar 27.

    PubMed 38533708
  • Hoeijmakers A, Licitra G, Meijer K, Lam KH, Molenaar P, Strijbis E, Killestein J. Disease severity classification using passively collected smartphone-based keystroke dynamics within multiple sclerosis. Sci Rep. 2023 Feb 1;13(1):1871. doi: 10.1038/s41598-023-28990-6.

    PubMed 36725975
  • de Abreu JLB, Sampaio CS, Benalcazar Jalkh EB, Hirata R. Analysis of the color matching of universal resin composites in anterior restorations. J Esthet Restor Dent. 2021 Mar;33(2):269-276. doi: 10.1111/jerd.12659. Epub 2020 Sep 29.

    PubMed 32989879
  • Zulekha, Vinay C, Uloopi KS, RojaRamya KS, Penmatsa C, Ramesh MV. Clinical performance of one shade universal composite resin and nanohybrid composite resin as full coronal esthetic restorations in primary maxillary incisors: A randomized controlled trial. J Indian Soc Pedod Prev Dent. 2022 Apr-Jun;40(2):159-164. doi: 10.4103/jisppd.jisppd_151_22.

    PubMed 35859408

Questions about this trial

What is this clinical trial studying?

A study testing Tokuyama Palfique Omnichroma composite restoration and 3M Filtek Z350 composite restoration in people with Early Childhood Caries (ECC), run by Goa Dental College at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Surface Luster and Surface texture (time frame: Baseline, 3 months, 6 months, and 12 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07716033, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in